Learn About Reticulohistiocytoma
- Reticulohistiocytoma
- Solitary histiocytoma
- Solitary reticulohistiocytosis
Mayo Clinic
Jithma Abeykoon is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Abeykoon and is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. Their top areas of expertise are Waldenstrom Macroglobulinemia, Histiocytosis, Reticulohistiocytoma, Erdheim-Chester Disease, and Bone Marrow Transplant. Dr. Abeykoon is currently accepting new patients.
J Haroche practices in Paris, France. Haroche and is rated as an Elite expert by MediFind in the treatment of Reticulohistiocytoma. Their top areas of expertise are Reticulohistiocytoma, Histiocytosis, Erdheim-Chester Disease, Non-Langerhans-Cell Histiocytosis, and Tissue Biopsy.
University Of Alabama Health Services Foundation, PC
Gaurav Goyal is a Hematologist Oncology specialist and a Hematologist in Birmingham, Alabama. Dr. Goyal and is rated as an Elite provider by MediFind in the treatment of Reticulohistiocytoma. His top areas of expertise are Histiocytosis, Reticulohistiocytoma, Non-Langerhans-Cell Histiocytosis, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Goyal is currently accepting new patients.
Summary: This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that is growing, spreading, or getting worse (progressive), has come back (relapsed) after previous treatment, or does not respond to therapy (refractory). Langerhans cell histiocytosis is a type of disease that occurs when the body makes too ma...
Summary: Prospective, interventional, open, randomized, single-center, non-commercial clinical trial to optimize treatment and dosage of vemurafenib in juvenile patients with histiocytosis resistant to conventional therapy and in whom the BRAF gene mutation has been found.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center